Talk:Pfizer Inc.

Competition

Despite Pfizer being the leading companies in the biotechnology and pharmaceutical industry, several other large, global drug manufacturers are in competition with Pfizer. These companies include Johnson and Johnson, Roche Holding AG, Novo Nordisk, Merck and Co, AbbVie Inc, and Eli Lilly and Co.

In FY 2022, Pfizer made $31.37 billion in net income out of $100.33 billion in annual revenue. The company's market capitalization was $227 billion as of market close on March 24, 2023 [1]. Market cap is used to determine a company's size and then evaluate the company's financial performance to other companies of various sizes. In investing, companies with larger market capitalizations are often safer investments as they represent more established companies with generally longer history in business carrying less risk than small-cap companies.

1. Johnson and Johnson:

• Market cap: $423 billion
• FY 2022 Revenue: $95 billion
• FY 2022 Net income: $17.9 billion
• Top drug by revenue (FY 2022): Darzalex
• Revenue from top drug (FY 2022): $7.9 billion [2]

Johnson and Johnson is known for its health products, pharmaceuticals and medical devices.

2. Novo Nordisk A/S (NVO):

• Market cap: $349 billion [3]
• FY 2022 Revenue: $43.5 billion
• FY 2022 Net income: $16.9 billion
• Top drug by revenue (FY 2022): Ozempic
• Revenue from top drug (FY 2022): $5.7 billion [4]

Novo Nordisk is a Norweigan pharmaceutical company that focuses on treating diabetes, obesity and other serious chronic diseases and conditions. Ozempic was Novo Nordisk's top selling drug in 2022 which is an insulin therapy delivered by injection.

3. Eli Lilly and Co:

• Market cap: $440 billion [5]
• FY 2022 Revenue: $28.5 billion
• FY 2022 Net income: $6.2 billion
• Top drug by revenue (FY 2022): Trulicity
• Revenue from top drug (FY 2022): $5.7 billion [6]

Eli Lilly is a global drug manufacturing company which focuses on discovering, developing, manufacturing and marketing human pharmaceutical products. The company's top selling drug in FY 2022 was Trulicity which is used to treat type 2 diabetes.

4. Abbvie Inc.

• Market Cap: $242 billion [7]
• FY 2022 Revenue: $58.1 billion
• FY 2022 Net Income: $11.8 billion
• Top Drug by Revenue (FY 2022): Humira
• Revenue from Top Drug (FY 2022): $18.6 billion ([8]

AbbVie is a global biopharmaceutical company engaged in research and development, manufacturing, commercializing and selling innovation medicines and therapies. Its medical products span a range of healthcare-related areas such as immuology, oncology, neuroscience, etc.

5. Merck and Co. Inc

• Market Cap: $289 billion
• FY 2022 Revenue: $59.3 billion
• FY 2022 Net Income: $16.4 billion
• Top Drug by Revenue (FY 2022): Keytruda
• Revenue from Top Drug (FY 2022): $20.9 billion [9]

The company offers prescription medicines, vaccines, biologic therapies, and animal health products. Its two operating segments are pharmaceutical and animal health.

Research report example

Take a look at this commended research report on Tesla, Inc. from the Stockhub platform: https://stockhub.co/research/Tesla,_Inc. While it has garnered positive feedback, remember that it's simply a reference - there's no obligation to adhere strictly to its style or content.

Key source(s) of information

A prime source of insightful information about this company is the company itself. Specifically, the annual report provides comprehensive details about its financial status and business progress. You can access this valuable resource at the following link: Pfizer's Annual Report. Another key source is that of the company's competitors.